|
Archived Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Central Nervous System Cancers |
1.00 |
12/23/2020 - 12:00am to 12/23/2021 - 12:00am |
|
NCCN Guidelines® Insights - Cervical Cancer, Version 1.2020 |
1.00 |
06/10/2020 - 12:00am to 06/10/2021 - 12:00am |
|
Recorded Presentation from the NCCN Pharmacy Updates: Novel Treatments for Neuroendocrine Tumors |
1.00 |
10/08/2020 - 12:00am to 09/28/2021 - 12:00am |
|
Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Multiple Myeloma |
1.00 |
12/23/2020 - 12:00am to 05/23/2021 - 12:00am |
|
New Approaches to Multiple Myeloma Therapy |
1.00 |
05/12/2020 - 12:00am to 05/12/2021 - 12:00am |
|
Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Central Nervous System Cancers |
1.00 |
10/13/2020 - 12:00am to 02/21/2021 - 12:00am |
|
Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Ovarian Cancer |
1.00 |
11/30/2020 - 12:00am to 03/14/2021 - 12:00am |
|
Selection of Optimal First-Line and Maintenance Therapies in Advanced Ovarian Cancer |
1.00 |
07/08/2020 - 12:00am to 03/01/2021 - 12:00am |
|
Recorded Presentation from the NCCN Pharmacy Updates: Emerging Strategies in the Treatment of Venous Thromboembolism |
1.00 |
12/24/2020 - 12:00am to 12/23/2021 - 12:00am |
|
Recognition and Management of Graft Versus Host Disease |
1.00 |
05/12/2020 - 12:00am to 03/01/2021 - 12:00am |
|
Recorded Presentation from the NCCN Pharmacy Updates: The Role of the Pharmacist in Smoking Cessation and Education of Patients with Cancer |
1.00 |
06/10/2020 - 12:00am to 06/08/2021 - 12:00am |
|
Archived Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Melanoma |
1.00 |
11/30/2020 - 12:00am to 11/30/2021 - 12:00am |
|
NCCN Guidelines® Insights - Rectal Cancer, Version 6.2020 |
1.00 |
07/10/2020 - 12:00am to 07/10/2021 - 12:00am |
|
Current Insights: Evolving Principles and Controversies of Cancer Risk Assessment and Management of Hereditary Cancers |
1.25 |
05/15/2020 - 12:00am to 03/01/2021 - 12:00am |
|
Role of Biosimilars in the Oncology Ecosystem |
1.25 |
05/15/2020 - 12:00am to 03/01/2021 - 12:00am |
Facebook
Twitter
LinkedIn
Forward